146 related articles for article (PubMed ID: 6263423)
21. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
22. Effect of acute organophosphorus exposure on 2', 3',-cyclic nucleotide 3'-phosphohydrolase activity in hen neural tissue.
Olajos EJ; Shopp G; Rosenblum I
Neurotoxicology; 1982 Jul; 3(1):146-50. PubMed ID: 6290952
[TBL] [Abstract][Full Text] [Related]
23. Spectrophotometric assay, solubilization and purification of brain 2':3'-cyclic nucleotide 3'-phosphodiesterase.
Nishizawa Y; Kurihara T; Takahashi Y
Biochem J; 1980 Oct; 191(1):71-82. PubMed ID: 6258586
[TBL] [Abstract][Full Text] [Related]
24. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
Nicholson CD; Shahid M; Bruin J; Barron E; Spiers I; de Boer J; van Amsterdam RG; Zaagsma J; Kelly JJ; Dent G
J Pharmacol Exp Ther; 1995 Aug; 274(2):678-87. PubMed ID: 7636728
[TBL] [Abstract][Full Text] [Related]
25. [Purification of cyclic nucleotide phosphodiesterase from the external segments of retinal rods; conjugation of the enzyme with an inhibitor].
Furaev VV; Dumler IL; Kazimirskiĭ AN; Etingof RN
Dokl Akad Nauk SSSR; 1978; 243(1):247-50. PubMed ID: 214282
[No Abstract] [Full Text] [Related]
26. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
Levin RM; Weiss B
Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
[No Abstract] [Full Text] [Related]
27. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
Reeves ML; Leigh BK; England PJ
Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
[TBL] [Abstract][Full Text] [Related]
28. An investigation of 2':3'-cyclic nucleotide 3'-phosphodiesterase (EC 3.1.4.37, CNP) in peripheral blood elements and CNS myelin.
Sheedlo HJ; Doran JE; Sprinkle TJ
Life Sci; 1984 Apr; 34(18):1731-7. PubMed ID: 6328143
[TBL] [Abstract][Full Text] [Related]
29. [Modulation of brain Ca2+-calmodulin-dependent phosphodiesterase activity by naphthalene sulfamides].
Shaĭkhin SM; Muratova MV; Belov AA; Khropov IuV; Kulagin SV
Biokhimiia; 1988 Aug; 53(8):1357-64. PubMed ID: 2847819
[TBL] [Abstract][Full Text] [Related]
30. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
Wynne DG; Poole-Wilson PA; Harding SE
Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
[TBL] [Abstract][Full Text] [Related]
31. [Action of cyclic nucleotide phosphodiesterase inhibitors on the acetylcholine potential].
Kafengauz BIu; Poskonova MA
Biull Eksp Biol Med; 1985 May; 99(5):522-4. PubMed ID: 2408691
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody production to human and bovine 2':3'-cyclic nucleotide 3'-phosphodiesterase (CNPase): high-specificity recognition in whole brain acetone powders and conservation of sequence between CNP1 and CNP2.
Sprinkle TJ; Agee JF; Tippins RB; Chamberlain CR; Faguet GB; De Vries GH
Brain Res; 1987 Nov; 426(2):349-57. PubMed ID: 2446713
[TBL] [Abstract][Full Text] [Related]
33. 1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases.
Chasin M; Harris DN; Phillips MB; Hess SM
Biochem Pharmacol; 1972 Sep; 21(18):2443-50. PubMed ID: 4345859
[No Abstract] [Full Text] [Related]
34. Studies on the Wolfgram high molecular weight CNS myelin proteins: relationship to 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Sprinkle TJ; Wells MR; Garver FA; Smith DB
J Neurochem; 1980 Nov; 35(5):1200-8. PubMed ID: 6256502
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
Dent G; Giembycz MA; Rabe KF; Barnes PJ
Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
[TBL] [Abstract][Full Text] [Related]
36. An immunochemical investigation of 2':3'-cyclic nucleotide 3'-phosphodiesterase (CNP) in bovine cerebrum and human oligodendroglioma.
Sheedlo HJ; Yaghmai F; Wolfe L; Sprinkle TJ
J Neurosci Res; 1985; 13(3):431-41. PubMed ID: 2580990
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cyclic nucleotide phosphodiesterases from pig coronary artery by benzo-separated analogues of 3-isobutyl-1-methylxanthine.
Schneller SW; Ibay AC; Martinson EA; Wells JN
J Med Chem; 1986 Jun; 29(6):972-8. PubMed ID: 2423691
[TBL] [Abstract][Full Text] [Related]
38. Heat-stable calmodulin-binding protein in rat testis. Inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase activity.
Ono T; Koide Y; Arai Y; Yamashita K
J Biol Chem; 1984 Jul; 259(14):9011-6. PubMed ID: 6086620
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination.
Gravel M; Peterson J; Yong VW; Kottis V; Trapp B; Braun PE
Mol Cell Neurosci; 1996 Jun; 7(6):453-66. PubMed ID: 8875429
[TBL] [Abstract][Full Text] [Related]
40. 2',3'-cyclic nucleotide phosphohydrolase activity determined using an image analyzer detection system.
Jacks AS; Jones MA
Anal Biochem; 1990 Feb; 184(2):321-4. PubMed ID: 2158249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
